Diabetes : Actualité Diabetes en direct - P2 | Bourse Reflex
Accueil > Tags > Diabetes

  • Toutes les actualités en rapport avec « Diabetes »

31/03 16:45 Diabetes - Apricus Biosciences Expands Patent Coverage in Mexico for Its Erectile Dysfunction Drug, Vitaros(R)

29/03 17:45 Diabetes - GLG Life Tech Corporation Announces Progress on the Development of the Healthy Sugar Market in China

24/03 15:55 Diabetes - Apricus Biosciences Adopts Shareholder Rights Plan

22/03 14:55 Diabetes - Apricus Biosciences Announces Poster Presentations on Progress of PrevOnco(TM) in Combination With NexACT(R) Technology at the American Association for Cancer Research 2011 Annual Meeting

15/03 15:30 Diabetes - Apricus Biosciences Announces Formation of Clinical Advisory Board as Part of Its Plans to Further the Clinical Development of Femprox(R)

10/03 16:00 Diabetes - Apricus Biosciences to Present at the Bio-Europe Spring 2011 Conference

08/03 16:00 Diabetes - Apricus Biosciences Announces Removal of Auditor's "Going Concern" Opinion From Its 2010 Form 10-K and Increased Cash Reserves

01/03 15:15 Diabetes - Apricus Biosciences Announces Expanded European Patent Coverage for MycoVa(TM) for Nail Fungus

28/02 13:30 Diabetes - Un consensus global exige une meilleure prise en charge de la santé des pieds des diabétiques

18/02 16:01 Diabetes - Addex Pharmaceuticals 2010 Financial Results Next Wednesday

17/02 15:15 Diabetes - Apricus Biosciences and FDA Initiate PrevOnco(TM) SPA Phase III Clinical Protocol Discussion

14/02 16:15 Diabetes - Apricus Biosciences and Neopharm Group Sign Licensing Agreement for Vitaros(R) in Israel for up to USD 4.35 Million, Plus Royalties

10/02 16:15 Diabetes - Apricus Biosciences to Present Review of Commercialization Plans for Vitaros(R) and Development of Product Pipeline at BioPartnering North America Conference(TM)

04/02 09:30 Diabetes - Des millions de cas de cancer sont évitables - les facteurs liés au mode de vie sont la clé pour sauver des vies

26/01 08:30 Diabetes - Le Rapiscan(R) (régadénoson) est le premier agoniste sélectif du récepteur de l'adénosine A2A à recevoir une autorisation de la Commission européenne pour aider au diagnostic des maladies coronariennes

19/01 17:45 Diabetes - Apricus Biosciences Reports Additional Analysis Showing That MycoVa(TM) is as Effective for the Treatment of Nail Fungus as the Current European Standard of Care for Topical Therapy, Loceryl(R)

06/01 22:00 Diabetes - L'aiguille innovante de Novo Nordisk - NovoTwist(R) - remporte le prix GOOD DESIGN(TM)

03/11 08:31 Diabetes - MORNING MEETING AOF FRANCE / EUROPE - Ouverture mitigée attendue

03/11 08:00 Diabetes - A SUIVRE AUJOURD'HUI... GENFIT

02/11 18:32 Diabetes - GENFIT présent à la convention BIO- Europe 2010 à Munich